BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32326378)

  • 41. MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
    Yamauchi T; Fujishima F; Tsunokake J; Kunimitsu A; Akaishi R; Ozawa Y; Fukutomi T; Okamoto H; Sato C; Taniyama Y; Kamei T; Ichinohasama R; Sasano H
    Int J Biol Markers; 2023 Jun; 38(2):105-113. PubMed ID: 37009661
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
    Shuen AY; Lanni S; Panigrahi GB; Edwards M; Yu L; Campbell BB; Mandel A; Zhang C; Zhukova N; Alharbi M; Bernstein M; Bowers DC; Carroll S; Cole KA; Constantini S; Crooks B; Dvir R; Farah R; Hijiya N; George B; Laetsch TW; Larouche V; Lindhorst S; Luiten RC; Magimairajan V; Mason G; Mason W; Mordechai O; Mushtaq N; Nicholas G; Oren M; Palma L; Pedroza LA; Ramdas J; Samuel D; Wolfe Schneider K; Seeley A; Semotiuk K; Shamvil A; Sumerauer D; Toledano H; Tomboc P; Wierman M; Van Damme A; Lee YY; Zapotocky M; Bouffet E; Durno C; Aronson M; Gallinger S; Foulkes WD; Malkin D; Tabori U; Pearson CE
    J Clin Oncol; 2019 Feb; 37(6):461-470. PubMed ID: 30608896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of mismatch repair proteins in urothelial carcinoma of the urinary bladder.
    Mohamedali R; Adhya AK; Mandal S; Mitra S
    Indian J Cancer; 2022; 59(2):279-281. PubMed ID: 35946190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of tobacco compound 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on the expression of epigenetically regulated genes in lung carcinogenesis.
    Jin SW; Im JS; Park JH; Kim HG; Lee GH; Kim SJ; Kwack SJ; Kim KB; Chung KH; Lee BM; Kacew S; Jeong HG; Kim HS
    J Toxicol Environ Health A; 2021 Dec; 84(24):1004-1019. PubMed ID: 34459362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
    Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
    Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and NNK reducing activities of carbonyl reductase and 11beta-hydroxysteroid dehydrogenase type 1 in human lung.
    Finckh C; Atalla A; Nagel G; Stinner B; Maser E
    Chem Biol Interact; 2001 Jan; 130-132(1-3):761-73. PubMed ID: 11306092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
    Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
    Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobacco-specific carcinogen nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces AKT activation in head and neck epithelia.
    Weber SM; Bornstein S; Li Y; Malkoski SP; Wang D; Rustgi AK; Kulesz-Martin MF; Wang XJ; Lu SL
    Int J Oncol; 2011 Nov; 39(5):1193-8. PubMed ID: 21822536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of pulmonary neoplasia in the smoke-exposed ferret by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): a model for human lung cancer.
    Kim Y; Liu XS; Liu C; Smith DE; Russell RM; Wang XD
    Cancer Lett; 2006 Mar; 234(2):209-19. PubMed ID: 15894421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells.
    Tsurutani J; Castillo SS; Brognard J; Granville CA; Zhang C; Gills JJ; Sayyah J; Dennis PA
    Carcinogenesis; 2005 Jul; 26(7):1182-95. PubMed ID: 15790591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.
    Castonguay A; Rioux N
    Carcinogenesis; 1997 Mar; 18(3):491-6. PubMed ID: 9067547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative functional genomics analysis of NNK tobacco-carcinogen induced lung adenocarcinoma development in Gprc5a-knockout mice.
    Fujimoto J; Kadara H; Men T; van Pelt C; Lotan D; Lotan R
    PLoS One; 2010 Jul; 5(7):e11847. PubMed ID: 20686609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 55. beta-carotene-induced changes in RARbeta isoform mRNA expression patterns do not influence lung adenoma multiplicity in the NNK-initiated A/J mouse model.
    Goralczyk R; Bachmann H; Wertz K; Lenz B; Riss G; Buchwald Hunziker P; Greatrix B; Aebischer CP
    Nutr Cancer; 2006; 54(2):252-62. PubMed ID: 16898870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.
    Lin RK; Hsieh YS; Lin P; Hsu HS; Chen CY; Tang YA; Lee CF; Wang YC
    J Clin Invest; 2010 Feb; 120(2):521-32. PubMed ID: 20093774
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of Lung Tumors and Mutational Analysis in FVB/N Mice Treated with the Tobacco Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone.
    Rothenberger NJ; Stabile LP
    Methods Mol Biol; 2020; 2102():149-160. PubMed ID: 31989553
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
    Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
    BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis.
    Li MY; Liu LZ; Li W; Ng CSH; Liu Y; Kong AWY; Zhao Z; Wang S; Qi H; Jia H; Yang S; Du J; Long X; Ho RLK; Chak ECW; Wan IYP; Mok TSK; Underwood MJ; Gali NK; Ning Z; Chen GG
    J Exp Clin Cancer Res; 2019 Aug; 38(1):359. PubMed ID: 31420013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone suppresses a newly identified anti-tumor IGFBP-3/IGFBP-3R system in lung cancer cells.
    Harada A; Jogie-Brahim S; Oh Y
    Lung Cancer; 2013 Jun; 80(3):270-7. PubMed ID: 23498137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.